Abstract
A Response to: Letter to the Editor Regarding "Geographical Differences in the Safety and Efficacy of Tofacitinib Versus TNFi: A PostHoc Analysis of ORAL Surveillance".
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have